Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
8 विचारों
administrator
08/09/23
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली